Dr. Scott Fleischauer, MD
What this data tells you about Dr. Fleischauer
Dr. Scott Fleischauer is a medical oncology in Arlington, TX, with 19 years in practice. Based on federal Medicare data, Dr. Fleischauer performed 22,214 Medicare services across 2,121 unique beneficiaries.
Between the years covered by Open Payments, Dr. Fleischauer received a total of $4,118 from 15 pharmaceutical and/or device companies across 25 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in medical oncology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Fleischauer is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Darbepoetin injection (Aranesp) for anemia | 12,810 | $2 | $20 |
| Contrast dye for imaging (iodine-based) | 3,861 | $0 | $3 |
| Blood draw (venipuncture) | 854 | $8 | $20 |
| Complete blood count (CBC) with differential | 838 | $8 | $36 |
| Comprehensive metabolic blood panel | 763 | $10 | $64 |
| Office visit, established patient (30-39 min) | 674 | $90 | $368 |
| Dexamethasone injection (steroid) | 510 | $0 | $1 |
| Ferritin level test (iron stores) | 194 | $13 | $60 |
| Iron level test | 194 | $6 | $27 |
| Iron binding capacity test | 194 | $9 | $35 |
| Hospital follow-up visit, moderate complexity | 132 | $61 | $247 |
| Lactate dehydrogenase (enzyme) level | 114 | $6 | $31 |
| Drug injection, under skin or into muscle | 98 | $11 | $96 |
| Administration of chemotherapy into vein, 1 hour or less | 98 | $102 | $707 |
| Reticulated (young) platelet measurement | 90 | $35 | $143 |
| Microscopic examination for white blood cells with manual cell count | 74 | $4 | $22 |
| Complete blood count (CBC), automated | 74 | $6 | $34 |
| Injection of additional new drug or substance into vein | 72 | $12 | $108 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 70 | $91 | $657 |
| Office visit, established patient, complex (40-54 min) | 69 | $136 | $496 |
| Nuclear medicine study from skull base to mid-thigh with ct scan | 66 | $1,152 | $4,802 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 52 | $23 | $157 |
| Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session | 49 | $285 | $2,762 |
| Ct scan of chest with contrast | 41 | $48 | $821 |
| CT scan of abdomen and pelvis with contrast | 36 | $179 | $1,067 |
| Radiation treatment delivery,3 or more separate treatment areas, custom blocking, tangential ports, wedges, rotational beam, compensators, electron beam; 11-19 mev | 31 | $186 | $700 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 30 | $49 | $313 |
| Irrigation of implanted venous access drug delivery device | 28 | $16 | $114 |
| New patient office visit, complex (60-74 min) | 26 | $165 | $709 |
| Administration of additional new drug or substance into vein, 1 hour or less | 24 | $51 | $344 |
| Initial hospital admission, moderate complexity | 21 | $97 | $470 |
| Injection, diphenhydramine hcl, up to 50 mg | 16 | $1 | $7 |
| New patient office visit (45-59 min) | 11 | $130 | $565 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
The majority of payments (70%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in medical oncology and does not inherently indicate bias, but patients may wish to be aware.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Fleischauer is a mixed practice specialist, with moderate Medicare volume, and speaking/promotional industry engagement, with 19 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Fleischauer experienced with darbepoetin injection (aranesp) for anemia?
Does Dr. Fleischauer receive payments from pharmaceutical companies?
How do Dr. Fleischauer's costs compare to other medical oncologys in Arlington?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology